Fauci Says Vaccine Might Be Ready by Late 2020

Ralph Ellis

August 31, 2020

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

Dr. Anthony Fauci says a coronavirus vaccine might be ready by the end of this year, but he warned that availability will not be widespread at first.

Speaking on WTOP's "Colors: A Dialogue on Race in American" podcast, Fauci said the development and distribution of vaccines is crucial to taming the pandemic.

"If we continue to have uncontrolled infections, it's very difficult to make a projection, but you could do multiple times of what is going on right now," said Fauci, the director of the National Institute of Allergy and Infectious Diseases and a member of the Coronavirus Task Force.

Fauci said that phase three clinical trials are underway for several vaccines, and "by the end of this calendar year and into 2021, we should know if we do indeed have a safe and effective vaccine."

"Theoretically, it could start happening towards the end of this year with limited numbers of doses," he said. "And as you get into 2021, you could start talking in tens of millions."

Drug companies will be making advance purchases and developing the means for large-scale production, he said. By the middle of 2021, Fauci said, hundreds of millions of doses might be available and by the end of 2021, billions of doses.

"So it's not going to be, everybody's going to have the availability of a vaccine in the beginning of 2021, but it will incrementally increase, hopefully rapidly," he said.

"Who's going to get it first?" he asked. "That's an important question. That's the reason why the standard way is to get independent advisory committees."

Fauci says that African Americans are subjected to "almost a double whammy" when it comes to the coronavirus.

First, they often have jobs that make social distancing difficult, he said. Second, African Americans have a higher incidence of comorbidities, such as diabetes, hypertension, obesity, heart disease, lung disease, kidney disease. 

"So I call it almost a double whammy, a double disadvantage," he said.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.